Skip to main content

Advertisement

SpringerLink
Log in

Screening for colorectal cancer

  • Symposium
  • Published:
International Journal of Colorectal Disease Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Stower MJ, Hardcastle JD (1985) Five year survival of patients with colorectal cancer treated in a regional hospital. Eur J Clin Oncol 11:119–123

    Google Scholar 

  2. Clarke DN, Jones P, Needham CD (1980) Outcome in colorectal carcinoma; seven year study of a population. Br Med J 1:431–435

    Google Scholar 

  3. Gill PG, Morris PJ (1978) The survival of patients with colorectal cancer treated in a regional hospital. Br J Surg 65:17–20

    Google Scholar 

  4. Morson BC (1974) The polyp-cancer sequence in the large bowel. Proc R Soc Med 67:451–457

    Google Scholar 

  5. Pierson RN Jr, Holt PR, Watson RM, et al. (1961) Aspirin and gastrointestinal bleeding: chromate 51 blood loss studies. Am J Med 31:259–265

    Google Scholar 

  6. Schwartz S, Ellefson M (1985) Quantitative fecal recovery of ingested Hemoglobin-heme in blood: comparison by HemoQuant assay with ingested meat and fish. Gastroenterology 89:19–26

    Google Scholar 

  7. Macrae FA, St John DJB (1982) Relationship between patterns of bleeding and Hemoccult sensitivity in patients with colorectal cancers or adenomas. Gastroenterology 82:891–898

    Google Scholar 

  8. Herzog P, Holtermüller KH, Preiss J, et al. (1982) Fecal blood loss in patients with colonic polyps: a comparison of measurements with51chromium-labeled erythrocytes and with the Hemoccult test. Gastroenterology 83:957–962

    Google Scholar 

  9. Doran J, Hardcastle JD (1982) Bleeding patterns in colorectal cancer: the effect of aspirin and implications for faecal occult blood testing. Br J Surg 69:711–713

    Google Scholar 

  10. Winawer SJ, Andrews M, Flehinger B, Sherlock P, Schotten-feld D, Miller DG (1980) Progress report on controlled trial of fecal occult blood testing for the detection of colorectal neoplasia. Cancer 45:2959–2964

    Google Scholar 

  11. Williams CB, Macrae FA, Bartram CB (1982) A prospective study of diagnostic methods in adenoma follow-up. Endoscopy 3:74–78

    Google Scholar 

  12. Caligiore P, Macrae FA, St John DJB, Rayner L, Legge JW (1982) Peroxidase levels in food: relevance to colorectal cancer screening. Am J Clin Nutr 35:1487–1489

    Google Scholar 

  13. Macrae FA, St John DJB, Caligiore P, Taylor L, Legge JW (1982) Optimal dietary conditions for Hemoccult testing. Gastroenterology 82:899–903

    Google Scholar 

  14. Songster CL, Barrows GH, Jarrett DD (1980) Immunochemical detection of faecal occult blood — a faecal smear punchdisc test. A new non-invasive screening test for colorectal cancer. Cancer 40:1099–1102

    Google Scholar 

  15. Williams JAR, Hunter R, Smith M, Coles ME, Hubert TW, Thomas DW (1982) Evaluation of an immunological test for occult bleeding from colorectal neoplasia. Aust N Z J Surg 52:617–621

    Google Scholar 

  16. McDonald C, Burford Y, Walls R, Goulston K (1985) Immunochemical testing for faecal occult blood in patients with colorectal cancer. Med J Aust 143:141–142

    Google Scholar 

  17. Vellacott KD, Baldwin RW, Hardcaste JD (1981) An immunofluorescent test for faecal occult blood. Lancet 1:18–19

    Google Scholar 

  18. Ahlquist DA, McGill DB, Schwartz S, Taylor WF, Owen RA (1985) Fecal blood levels in health and disease. A study using HemoQuant. N Engl J Med 312:1422–1428

    Google Scholar 

  19. Causes of deaths 1981 (1983) Official statistics of Sweden, National Central Bureau of Statistics Stockholm

  20. Ekelund G, Carlsson U, Janzon L (1985) The feasibility of large scale population screening. Br J Surg 72 (Suppl) 71–72

    Google Scholar 

  21. Tabár L, Gad A, Homberg LA, Ljungquist U, Fagerberg CJG, Baldetorp L, Gröntoft O, Lundström B, Månsson JC, Eklund G, Day NE, Pettersson F (1985) Reduction in mortality from breast cancer after mass screening with mammography. Lancet 1:189–832

    Google Scholar 

  22. Kronborg O (1984) Mass screening for colorectal cancer. Scand J Gastroenterol 19:1–5

    Google Scholar 

  23. SPRI-rapport 122 (1983) SPRI, Stockholm

  24. Cancer Incidence in Sweden 1981 (1984). National Board on Health and Wellfare. The Cancer Registry, Stockholm

  25. Cancer Incidence in Southern Sweden 1978–1982 (1984). Southern Swedish Regional Tumour Registry, Lund

  26. Ekelund G (1980) Cancer risk with single and multiple adenomas: synchronous and metachronous tumours. In: Winawer S, Schottenfeld D, Sherlock P (eds) Colorectal cancer: prevention, epidemiology and screening. Raven Press, New York, pp 151–155

    Google Scholar 

  27. Herwig E (1975) Krankheitsfrüherkennung Krebs — Frauen und Männer. Aufbereitung und Interpretation der Untersuchungsergebnisse aus den gesetzlichen Früherkennungsmaßnahmen 1972. Wissenschaftliche Reihe des Zentralinstituts für die kassenärztliche Versorgung in der Bundesrepublik Deutschland. Band 1. Deutscher Ärzte-Verlag, Cologne

  28. Schwartz F-W, Holstein H, Brecht JG (1979) Kolorektale Krebsfrüherkennung mittels Nachweis von okkultem Blut im Stuhl — Erste Ergebnisse. Teilauswertung der Ergebnisse im Rahmen des gesetzlichen Früherkennungsprogramms in der Bundesrepublik Deutschland 1977. Deutsches Ärzteblatt 76: 1223–1228

    Google Scholar 

  29. Brecht JG, Robra BP, Schwartz FW (1984) Ergebnisse des kolorektalen Screenings im Rahmen des gesetzlichen Krebsfrüherkennungsprogramms 1981. In: Frühmorgen P (ed) Prävention und Früherkennung des kolorektalen Karzinoms. Springer, Berlin Heidelberg New York Tokyo, pp 229–235

    Google Scholar 

  30. National Institutes of Health (ed) (1979) Screening and early detection of colorectal cancer: Consensus Development Conference. Proceedings, June 26–28, 1978. NIH Publication No. 80–2075

  31. American Cancer Society (ed) (1980) Guidelines for the cancer — related checkup: recommendations and rationale. CA 30:194–240

  32. Gnauck R (1980) The effect of Haemoccult-screening. In: Goerttler K (ed) Early detection of colorectal cancer. Wachtholz, Nürnberg, pp 72–80

    Google Scholar 

  33. Dales LG, Friedmann GD, Ramacharan S, et al. (1973) Multiphasic Checkup Evaluation Study. 3. Outpatient clinic utilization, hospitalization, and mortality experience after seven years. Prev Med 2 221–235

    Google Scholar 

  34. Robra B-P, Brecht JG, Wagner P, Schwartz FW (1984) Regionale Analyse der Beteiligung am „gesetzlichen“ Krebsfrüherkennungsprogramm in der Bundesrepublik Deutschland 1981. Öffentl Gesundh-Wes 46:499–503

    Google Scholar 

  35. Robra B-P, Schwartz FW (1986) Experiences with a nationwide screening programme for colorectal cancer in the Federal Republic of Germany. (in press)

  36. Kleinbaum DG, Kupper LL, Morgenstern H (1982) (ed) Epidemiologic research. Principles and quantitative methods. Lifetime Learning Publications, Belmont

    Google Scholar 

  37. Blum U, Ungeheuer E, Cappel J (1984) Sind aus chirurgischer Sicht durch Screeninguntersuchung beim kolorektalen Karzinom günstigere Tumorstadien zu erfassen? In: Frühmorgen P (ed) Prävention und Früherkennung des kolorektalen Karzinoms. Springer, Berlin Heidelberg New York Tokyo, pp 201–206

    Google Scholar 

  38. Eddy DM (1980) Screening for cancer — theory, analysis and design. Prentice Hall, Englewood Cliffs, New Jersey

    Google Scholar 

  39. Gnauck R (1980) World Health Organization Criteria for Screening. Colorectal Cancer: Prevention, Epidemiology and Screening. Raven Press, New York

    Google Scholar 

  40. Ribet A, Escourrou J, Frexinos J, Delpu J (1980) Screening for colorectal tumors. Results of two years experience. Cancer detection and prevention. 3:449–461

    Google Scholar 

  41. Gilbertsen VA, McHugh R, Schuman L, et al. (1980) The earlier detection of colorectal cancers: a preliminary report of the results of the occult blood study. Cancer 45:2899

    Google Scholar 

  42. Taylor WF, Fontana RS (1972) Biometrie design of the Mayo Lung Project for early detection and localization of bronchogenic carcinoma. Cancer 30:1344–1347

    Google Scholar 

  43. Schork MH, Remington R (1967) Determination of the number of subjects needed for experimental epidemiologic studies of the effect of increased physical activity on the incidence of coronary heart disease: Preliminary considerations. In: Karvonen MJ, Berry AJ (eds) Physical activity of the heart, Chapter 25. Thomas, Springfield, Ill.

    Google Scholar 

  44. Stroehlein JR, Fairbanks VF, Go VLW, et al. (1976) Hemoccult stool tests: false negative results due to storage of specimens. Mayo Clin Proc 51:548–552

    Google Scholar 

  45. Wells HJ, Pagano JF (1977) “Hemoccult” test: reversal of false negative results due to storage. Gastroenterology 72:1148

    Google Scholar 

  46. Gilbertsen VA, Williams SE, Schuman L, McHugh R (1979) Colonoscopy in the detection of carcinoma of the intestine. Surg Gynecol Obstet 149:877

    Google Scholar 

  47. Winchester DP, Shull JH, Scanlon EF, et al. (1980) A mass screening program for colorectal cancer using chemical testing for occult blood in the stool. Cancer 45:2955–2958

    Google Scholar 

  48. Sontag SJ, Durczak C, Aranha GV, et al. (1983) Fecal occult blood screening for colorectal cancer in a Veterans Administration hospital. Am J Surg 145:89–93

    Google Scholar 

  49. Hardcastle JD, Farrands PA, Balfour TW, et al. (1983) Controlled trial of faecal occult blood testing in the detection of colorectal cancer. Lancet 2:1–4

    Google Scholar 

  50. Simon JB (1985) Occult blood screening for colorectal carcinoma: a critical review. Gastroenterology 88:820–837

    Google Scholar 

  51. Cole P, Morrison AS (1980) Basic issues in population screening for cancer. J Natl Cancer Inst 64:1263–1272

    Google Scholar 

  52. Dickinson JA (1982) Biases in the assessment of colorectal cancer screening programmes using Hemoccult. Aust NZ J Surg 52:622–625

    Google Scholar 

  53. Irons GV Jr, Kirsner JB (1965) Routine chemical tests of the stool for occult blood: an evaluation. Am J Med Sci 249: 247–260

    Google Scholar 

  54. Fleisher M, Schwartz MK, Winawer SJ (1977) The falsenegative Hemoccult test. Gastroenterology 72:782–784

    Google Scholar 

  55. Lifton LJ, Kreiser J (1982) False-positive stool occult blood tests caused by iron preparations. A controlled study and review of literature. Gastroenterology 83:860–863

    Google Scholar 

  56. Jaffe RM, Kasten B, Young DS, et al. (1975) False-negative stool occult blood tests caused by ingestion of ascorbic acid (vitamin C). Ann Intern Med 83:824–826

    Google Scholar 

  57. Heinrich HC, Igačić F (1980) Comparative studies on the “in vivo”-sensitivity of four commercial pseudoperoxidase-based faecal occult blood tests in relation to actual blood losses as calculated from whole body-59Fe-elimination rates. Klin Wochenschr 58:1283–1297

    Google Scholar 

  58. Adlercreutz H, Partanen P, Virkola P, et al. (1984) Five guaiac-based tests for occult blood in faeces compared in vitro and in vivo. Scand J Clin Lab Invest 44:519–528

    Google Scholar 

  59. Turunen MJ, Liewendahl K, Partanen P, et al. (1984) Immunological detection of faecal occult blood in colorectal cancer. Br J Cancer 49:141–148

    Google Scholar 

  60. Stroehlein JR, Fairbanks VF, McGill DB, et al. (1976) Hemoccult detection of fecal occult blood quantitated by radioassay. Dig Dis 21:841–844

    Google Scholar 

  61. Crowley ML, Freeman LD, Mottet MD, et al. (1983) Sensitivity of guaiac-impregnated cards for the detection of colorectal neoplasia. J Clin Gastroenterol 5:127–130

    Google Scholar 

  62. Miller SF, Knight AR (1977) The early detection of colorectal cancer. Cancer 40:945–949

    Google Scholar 

  63. Elwood TW, Erickson A, Lieberman S (1978) Comparative educational approaches to screening for colorectal cancer. Am J Public Health 68:135–138

    Google Scholar 

  64. Winawer SJ, Sherlock P (1982) Surveillance for colorectal cancer in average-risk patients, familial high-risk groups, and patients with adenomas. Cancer 50:2609–2614

    Google Scholar 

  65. Hastings JB (1974) Mass screening for colorectal cancer. Am J Surg 127:228–233

    Google Scholar 

  66. Sterchi JM (1979) Screening for colorectal cancer. South Med J 72:1144–1146

    Google Scholar 

  67. Bralow SP, Kopel J (1979) Hemoccult screening for colorectal cancer. An impact study on Sarasota, Florida. J Fla Med Assoc 66:915–919

    Google Scholar 

  68. Norfleet RG, Roberts RC (1983) Hemoccult screening for colorectal neoplasms. Report of a mail-out project without dietary restriction in a prepaid helath plan. Wisconsin Med J 82:23–26

    Google Scholar 

  69. Holliday HW, Hardcastle JD (1979) Delay in diagnosis and treatment of symptomatic colorectal cancer. Lancet 1:309–311

    Google Scholar 

  70. Farrands PA, Hardcastle JD, Chamberlain J, Moss S (1984) Factors affecting compliance with screening for colorectal cancer. Community Medicine 6:12–19

    Google Scholar 

  71. Chisholm EM, Giles GR (1984) The role of a symptom questionnaire combined with faecal occult blood studies in large bowel cancer screening. Br J Surg 71:A896

    Google Scholar 

  72. Armitage NC, Farrands PA, Macott KD, Hardcastle JD (1984) Faecal occult blood screening in symptomatic patients in general practice. Gut 25(10): A1171–1172

    Google Scholar 

  73. Barrows GH, Burton RM, Jarrett DD, Russell GG, Alford MD, Songster CL (1978) Immunochemical detection of human blood in faeces. Am J Clin Pathol 69:342

    Google Scholar 

  74. Ahlquist DA, McGill DB, Schwartz S, Taylor WF, Ellefson M, Owen RA (1984) HemoQuant, a new quantitative assay for fecal hemoglobin. Ann Intern Med 101:297–302

    Google Scholar 

  75. Macrae FA, St John DJB (1982) Relationship between patterns of bleeding and Haemoccult sensitivity in patients with colorectal cancer or adenomas. Gastroenterology 82: 891–898

    Google Scholar 

  76. Farrands PA, Hardcastle JD (1983) Accuracy of occult blood tests over a six-day period. Clin Oncol 9:217–225

    Google Scholar 

  77. Hardcastle JD, Armitage NC, Chamberlain JC, Balfour TW, Amar SS (1985) A control trial of faecal occult blood screening for colorectal cancer: 2 year results. Br J Surg 72:S69

    Google Scholar 

  78. Hardcastle JD, Armitage NC, Chamberlain JC, Amar SS, James PD, Balfour TW (1986) Faecal occult blood screening for colorectal cancer in the general population. Results of a controlled trial. Cancer (in press)

  79. Armitage NC, Hardcastle JD, Amar SS, Balfour TW, Haynes J, James PD (1985) A comparison of an immunological faecal occult blood test Fecatwin Sensitive/Feca EIA with Haemoccult in population screening for colorectal cancer. Br J Cancer 51:799–80415

    Google Scholar 

  80. Miller SF, Knight R (1977) The early detection of colorectal cancer. Cancer 40:945–949

    Google Scholar 

Download references

Author information

Author notes

  1. F. Macrae

    Present address: Department of Gastroenterology, The Royal Melbourne Hospital, 3050, Victoria, Australia

  2. G. Ekelund

    Present address: Department of Surgery, University of Lund, Malmö General Hospital, S-214, Malmö, Sweden

  3. B. P. Robra

    Present address: Zentralinstitut für Kassenärztliche Versorgung in der Bundesrepublik, Cologne, FRG

  4. R. Gnauck

    Present address: Fachbereich Gastroenterologie, Deutsche Klinik für Diagnostik, Wiesbaden, FRG

  5. H. Ribet &  J. Escourrou

    Present address: Hôpital de Rangueil, Toulouse, France

  6. J. H. Bond

    Present address: Gastroenterology Section, Minneapolis VA Medical Center, 54th Street & 48th Ave South, 55417, Minneapolis, MN, USA

  7. N. C. Armitage

    Present address: Department of Surgery, University Hospital, NG7 2UH, Nottingham, UK

  8. J. B. Simon

    Present address: Division of Gastroenterology, Department of Medicine, Kingston General Hospital, 78 Barrie Street, K7L 3J7, Kingston, Ontario, Canada

  9. J. D. Hardcastle (Moderator)

    Present address: Queen's Medical Centre, University Hospital, Clifton Boulevard, NG7 2UH, Nottingham, UK

Authors and Affiliations

    Authors
    1. F. Macrae
      View author publications

      You can also search for this author in PubMed Google Scholar

    2. G. Ekelund
      View author publications

      You can also search for this author in PubMed Google Scholar

    3. B. P. Robra
      View author publications

      You can also search for this author in PubMed Google Scholar

    4. R. Gnauck
      View author publications

      You can also search for this author in PubMed Google Scholar

    5. H. Ribet
      View author publications

      You can also search for this author in PubMed Google Scholar

    6. J. Escourrou
      View author publications

      You can also search for this author in PubMed Google Scholar

    7. J. H. Bond
      View author publications

      You can also search for this author in PubMed Google Scholar

    8. N. C. Armitage
      View author publications

      You can also search for this author in PubMed Google Scholar

    9. J. B. Simon
      View author publications

      You can also search for this author in PubMed Google Scholar

    10. J. D. Hardcastle
      View author publications

      You can also search for this author in PubMed Google Scholar

    Rights and permissions

    Reprints and permissions

    About this article

    Cite this article

    Macrae, F., Ekelund, G., Robra, B.P. et al. Screening for colorectal cancer. Int J Colorect Dis 1, 63–78 (1986). https://doi.org/10.1007/BF01648410

    Download citation

    • Issue Date:

    • DOI: https://doi.org/10.1007/BF01648410

    Keywords

    Search

    Navigation